New Zealand markets closed

Hoth Therapeutics, Inc. (HOTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9600-0.0006 (-0.06%)
At close: 04:00PM EDT
0.9339 -0.03 (-2.72%)
After hours: 04:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.69M
Enterprise value -2.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.60
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.58

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 3-66.55%
S&P500 52-week change 323.76%
52-week high 33.3700
52-week low 30.9000
50-day moving average 31.1744
200-day moving average 31.3424

Share statistics

Avg vol (3-month) 3475.71k
Avg vol (10-day) 3286.64k
Shares outstanding 54.89M
Implied shares outstanding 64.89M
Float 84.33M
% held by insiders 11.46%
% held by institutions 110.09%
Shares short (15 May 2024) 488.57k
Short ratio (15 May 2024) 43.06
Short % of float (15 May 2024) 42.08%
Short % of shares outstanding (15 May 2024) 41.81%
Shares short (prior month 15 Apr 2024) 4146.58k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 326 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-43.01%
Return on equity (ttm)-78.21%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-7.7M
Diluted EPS (ttm)-1.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.56M
Total cash per share (mrq)1.55
Total debt (mrq)48.22k
Total debt/equity (mrq)0.62%
Current ratio (mrq)13.14
Book value per share (mrq)1.78

Cash flow statement

Operating cash flow (ttm)-7.88M
Levered free cash flow (ttm)-5.39M